(Q38195589)

30 August 2017

1 reference

title

A critical appraisal of CSF monoamine metabolite studies in schizophrenia (English)

1 reference

30 August 2017

1 reference

Widerlöv E

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

30 August 2017

published in

1 reference

30 August 2017

volume

537

1 reference

30 August 2017

page(s)

309-323

1 reference

Dopamine and the pharmacology of schizophrenia: the state of the evidence

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

The dopamine hypothesis: an overview of studies with schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Increased brain dopamine and dopamine receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Increased dopamine-receptor sensitivity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Central dopamine turnover in schizophrenic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Family history and CSF homovanillic acid pattern during neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Norepinephrine and 3-methoxy-4-hydroxyphenyl glycol gradients in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Chemical Anatomy of the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Dopamine modulates cholecystokinin release in neostriatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Delta-sleep inducing peptide in cerebrospinal fluid from schizophrenics, depressives and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

Reliability of Norepinephrine and Major Monoamine Metabolite Measurements in CSF of Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

5-Hydroxyindoles in Human Cerebrospinal Fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42115.X

10.1111/J.1749-6632.1988.TB42115.X

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference